⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001780426

Buck Jill

Reports to the SEC for 2 companies · SAINT-LAURENT, A8

Transactions

8

Companies

2

Filings

6

CIK

0001780426

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-30	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Development Officer	AAward	+195K sh	—	—	195,000
2025-07-08	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Development Officer	AAward	+100K sh	—	—	100,000
2021-03-04	TCRTAlaunos Therapeutics, Inc.A Award	EVP, GM Gene Therapy	AAward	+31.5K sh	—	—	231,016
2021-03-04	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	EVP, GM Gene Therapy	AAward	+236K sh	—	—	236,250
2021-01-08	TCRTAlaunos Therapeutics, Inc.S Sale	EVP, GM Gene Therapy	SSale	−27.9K sh	$3.12	−$87K	199,516
2020-01-29	TCRTAlaunos Therapeutics, Inc.A Award	EVP, GM Gene Therapy	AAward	+53.7K sh	—	—	227,410
2020-01-29	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	EVP, GM Gene Therapy	AAward	+82.6K sh	—	—	82,600
2020-01-02	TCRTAlaunos Therapeutics, Inc.S Sale	EVP, GM Gene Therapy	SSale	−27.9K sh	$4.55	−$127K	173,710

Recent filings

6

Accepted (ET)
Feb 34
Buck Jill0000929638-26-000477
SEC(opens sec.gov)
Jul 104
Buck Jill0000929638-25-002554
SEC(opens sec.gov)
Mar 84
Buck Jill0001209191-21-018632
SEC(opens sec.gov)
Jan 124
Buck Jill0001209191-21-003245
SEC(opens sec.gov)
Jan 314
Buck Jill0001209191-20-005778
SEC(opens sec.gov)
Jan 34
Buck Jill0001209191-20-001167
SEC(opens sec.gov)

Companies

2

Address

C/O 4868 RUE LEVY, SUITE 220

SAINT-LAURENT, A8, H4R 2P1